What is Medpace Holdings, Inc.'s asia-pacific — PP&E (net)?

Medpace Holdings, Inc. (MEDP) reported asia-pacific — PP&E (net) of $14.91M in Q4 2025.

What does asia-pacific — PP&E (net) mean?

This metric represents the net book value of tangible assets, such as laboratory facilities, office infrastructure, and clinical equipment, located within the Asia-Pacific geographic segment. It reflects the capital investment required to support regional clinical trial operations and bioanalytical service delivery. Tracking this value helps investors understand the company's physical footprint and capacity expansion efforts in this specific market.

Medpace Holdings, Inc. (MEDP) Asia-Pacific — PP&E (Net)

Screener

Other geography segments

Total Europe

$29.82M+14.6%

Europe, Other

$6.82M-8.5%

Other

$2.43M+2.9%

Similar metrics at other companies

VEEVAsia Pacific — PP&E (Net)

$4.12M+28.6%

TELAsia Pacific — PP&E (Net)

$1.34B+14.2%

WKCAsia Pacific — PP&E (Net)

$11.7M+13.6%

INVEAsia Pacific — PP&E (Net)

$6.01M-14.3%

SESAsia Pacific — PP&E (Net)

$18.35M-23.7%

ACCOAsia Pacific — PP&E (Net)

$600K0.0%

Other financials

Income statement

See full

Revenue$707.3M+17.2%

Operating income$146.8M+16.2%

Net income$121.4M+34.5%

EPS (diluted)$4.25+37.1%

Balance sheet

See full

Cash & equivalents$502.7M+985%

Total debt$144.1M-3.8%

Total equity$433.9M+152%

Total assets$2.1B+30.9%

Cash flow

See full

Operating cash flow$162.0M+9.1%

CapEx$23.9M+291%

Free cash flow$138.1M-3.0%

Valuation

See full

Market cap$16.41B+35.7%

Enterprise value$16.05B+31.6%

P/E33.4×+4.5×

P/S5.9×+0.5×

Profitability

See full

Operating margin21%-0.4pp

Net margin17.7%-1.1pp

FCF margin25.4%-0.6pp

Returns & leverage

See full

Return on equity162.2%+72.8pp

Debt / equity0.3×-0.5×

Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Medpace Holdings, Inc.’s 10-K, filed February 10, 2026.

Filed: Feb 10, 2026, 4:03 PM EST
Fiscal year: FY2025
Accession: 0001668397-26-000006

Line item	2025	2024
United States	$83,898	$80,692
Europe
Belgium	22,998	18,557
Other	6,822	7,456
Total Europe	29,820	26,013
Asia-Pacific	14,910	14,552
Other	2,427	2,358
Total property and equipment, net	$131,055	$123,615

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Medpace Holdings, Inc.'s asia-pacific — PP&E (net)?: Medpace Holdings, Inc. (MEDP) reported asia-pacific — PP&E (net) of $14.91M in Q4 2025.
What does asia-pacific — PP&E (net) mean?: This metric represents the net book value of tangible assets, such as laboratory facilities, office infrastructure, and clinical equipment, located within the Asia-Pacific geographic segment. It reflects the capital investment required to support regional clinical trial operations and bioanalytical service delivery. Tracking this value helps investors understand the company's physical footprint and capacity expansion efforts in this specific market.